Latest Advances

  • Condition: Chronic Obstructive Pulmonary Disease (COPD)
  • Journal: South African family practice : official journal of the South African Academy of Family Practice/Primary Care
  • Treatment Used: Inhaled Corticosteroids (ICS)
  • Number of Patients: 0
  • Published —
This article discusses the treatment of chronic obstructive pulmonary disease (COPD) with inhaled corticosteroids.
  • Condition: Severe Eosinophilic Asthma
  • Journal: Tuberkuloz ve toraks
  • Treatment Used: Anti-Interleukin-5 Treatments
  • Number of Patients: 0
  • Published —
This study evaluated the effectiveness of anti-interleukin-5 treatments in patients with severe eosinophilic asthma (asthma with an elevated eosinophil count).
  • Condition: Bipolar Disorder/Eosinophilic Pneumonia
  • Journal: Revue des maladies respiratoires
  • Treatment Used: Sodium Divalproate
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patient with bipolar disorder (mood disorder) who was treated by sodium divalproate for more than 2 years and was hospitalized for eosinophilic pneumonia (disease in which an eosinophil, a type of white blood cell, accumulates in the lungs).
  • Condition: Hydatid Cyst (HC) Disease
  • Journal: Nigerian journal of clinical practice
  • Treatment Used: Open Surgery and Medical Treatments
  • Number of Patients: 78
  • Published —
This study evaluated the clinical findings and laboratory results of patients with hydatid (parasitic) disease.
  • Condition: COVID-19
  • Journal: Cytokine & growth factor reviews
  • Treatment Used: IL-15 immunotherapy
  • Number of Patients: 0
  • Published —
The study researched the use of IL-15 immunotherapy in patients with COVID-19.
  • Condition: Eosinophilic Cholecystitis with Common Bile Duct Sludge and Cholangitis
  • Journal: JNMA; journal of the Nepal Medical Association
  • Treatment Used: Cholecystectomy and Common Bile Duct Exploration
  • Number of Patients: 1
  • Published —
This case report describes a 27-year female diagnosed with eosinophilic cholecystitis (gallbladder inflammation) and cholangiopathy (common bile duct disease) treated with cholecystectomy and common bile duct exploration.
  • Condition: Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
  • Journal: Clinical and experimental rheumatology
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: 0
  • Published —
This article discusses the management of interstitial lung disease in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis.
  • Condition: Cough with Hypereosinophilic Syndrome
  • Journal: BMC pulmonary medicine
  • Treatment Used: Imatinib
  • Number of Patients: 411
  • Published —
This study investigated the incidence of cough and airway eosinophilic inflammation in patients with hypereosinophilic syndrome.
  • Condition: Idiopathic Chronic Eosinophilic Pneumonia
  • Journal: Lung
  • Treatment Used: Mepolizumab
  • Number of Patients: 10
  • Published —
The study researched the outcomes of using Mepolizumab in treating idiopathic chronic eosinophilic pneumonia (ICEP).
  • Condition: Chronic Eosinophilic Pneumonia
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Benralizumab
  • Number of Patients: 1
  • Published —
This case report describes a patient with chronic eosinophilic pneumonia that was treated using benralizumab.
  • Condition: Eosinophilic Fasciitis
  • Journal: Clinical rheumatology
  • Treatment Used: Tocilizumab
  • Number of Patients: 1
  • Published —
This case presented a patient with eosinophilic fasciitis treated with tocilizumab.
  • Condition: Chronic Obstructive Pulmonary Disease (COPD)
  • Journal: Chest
  • Treatment Used: Long-Acting Muscarinic Antagonist (LAMA), a Long-Acting Beta2 -Agonist (LABA), and an Inhaled Corticosteroid (ICS) (LAMA-LABA-ICS) vs a long-acting muscarinic antagonist (LAMA) and a long-acting beta2-agonist (LABA) (LAMA-LABA)
  • Number of Patients: 6921
  • Published —
This study compared the effectiveness and safety of triple therapy with a long-acting muscarinic antagonist (LAMA), a long-acting beta2-agonist (LABA), and an inhaled corticosteroid (ICS) versus long-acting muscarinic antagonist (LAMA) and a long-acting beta2-agonist (LABA) in patients with chronic obstructive pulmonary disease (chronic inflammatory lung disease that causes obstructed airflow from the lungs; COPD).
Showing 1-12 of 32